<VariationArchive VariationID="2003897" VariationName="NM_001754.5(RUNX1):c.782dup (p.Gln262fs)" VariationType="Duplication" Accession="VCV002003897" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2051954" VariationID="2003897">
      <GeneList>
        <Gene Symbol="RUNX1" FullName="RUNX family transcription factor 1" GeneID="861" HGNC_ID="HGNC:10471" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>21q22.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34787801" stop="35049302" display_start="34787801" display_stop="35049302" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36160097" stop="36421594" display_start="36160097" display_stop="36421594" Strand="-" />
          </Location>
          <OMIM>151385</OMIM>
          <Haploinsufficiency last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-06-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RUNX1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001754.5(RUNX1):c.782dup (p.Gln262fs)</Name>
      <CanonicalSPDI>NC_000021.9:34834432:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>21q22.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="21" Accession="NC_000021.9" start="34834432" stop="34834433" display_start="34834432" display_stop="34834433" variantLength="1" positionVCF="34834432" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="21" Accession="NC_000021.8" start="36206729" stop="36206730" display_start="36206729" display_stop="36206730" variantLength="1" positionVCF="36206729" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <OtherNameList>
        <Name>NM_001754.5(RUNX1):c.782dup</Name>
        <Name>p.Gln262fs</Name>
      </OtherNameList>
      <ProteinChange>Q235fs</ProteinChange>
      <ProteinChange>Q262fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_482" sequenceAccession="LRG_482">
            <Expression>LRG_482:g.1155279dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_482t1" sequenceAccession="LRG_482t1">
            <Expression>LRG_482t1:c.780dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_482p1" sequenceAccession="LRG_482p1" change="p.Gln262Serfs">
            <Expression>LRG_482p1:p.Gln262Serfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.8" sequenceAccession="NC_000021" sequenceVersion="8" change="g.36206732dup" Assembly="GRCh37">
            <Expression>NC_000021.8:g.36206732dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000021.9" sequenceAccession="NC_000021" sequenceVersion="9" change="g.34834435dup" Assembly="GRCh38">
            <Expression>NC_000021.9:g.34834435dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011402.2" sequenceAccession="NG_011402" sequenceVersion="2" change="g.1155279dup">
            <Expression>NG_011402.2:g.1155279dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001001890.3" sequenceAccession="NM_001001890" sequenceVersion="3" change="c.701dup">
            <Expression>NM_001001890.3:c.701dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001001890.1" sequenceAccession="NP_001001890" sequenceVersion="1" change="p.Gln235fs">
            <Expression>NP_001001890.1:p.Gln235fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001122607.2" sequenceAccession="NM_001122607" sequenceVersion="2" change="c.701dup">
            <Expression>NM_001122607.2:c.701dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001116079.1" sequenceAccession="NP_001116079" sequenceVersion="1" change="p.Gln235fs">
            <Expression>NP_001116079.1:p.Gln235fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001754.5" sequenceAccession="NM_001754" sequenceVersion="5" change="c.782dup" MANESelect="true">
            <Expression>NM_001754.5:c.782dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001745.2" sequenceAccession="NP_001745" sequenceVersion="2" change="p.Gln262fs">
            <Expression>NP_001745.2:p.Gln262fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001754.5(RUNX1):c.782dup (p.Gln262fs) AND Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" Accession="RCV002828118" Version="2">
        <ClassifiedConditionList TraitSetID="3994">
          <ClassifiedCondition DB="MedGen" ID="C1832388">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001754.5(RUNX1):c.782dup (p.Gln262fs) AND Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" Accession="RCV003448469" Version="1">
        <ClassifiedConditionList TraitSetID="54065">
          <ClassifiedCondition DB="MedGen" ID="CN281654">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2023-12-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18723428</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22318203</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25840971</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31064749</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32208489</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/705119d9-ded3-44b9-97e6-4f50c9a0dc75</URL>
        </Citation>
        <DescriptionHistory Dated="2023-12-15">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="54065" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="53344" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematologic cancer predisposition syndrome</ElementValue>
                <XRef ID="MONDO:0011071" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10352" />
                <XRef ID="10352" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="CN281654" DB="MedGen" />
              <XRef ID="MONDO:0011071" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3994" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="3980" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1</ElementValue>
                <XRef ID="MONDO:0100083" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial Platelet Disorder with Propensity to Acute Myelogenous Leukemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Platelet disorder, Aspirin-like</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial platelet disorder with associated myeloid malignancy</ElementValue>
                <XRef ID="Familial+Platelet+Disorder+with+Associated+Myeloid+Malignancy/2765" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial thrombocytopenia with propensity to acute myelogenous leukemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">FPDMM</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">FPD/AML</ElementValue>
                <XRef Type="MIM" ID="601399" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">RUNX1 familial platelet disorder with associated myeloid malignancies (RUNX1-FPDMM) is characterized by prolonged bleeding and/or easy bruising and an increased risk of developing a hematologic malignancy. RUNX1-FPDMM is characterized by thrombocytopenia with normal platelet size; bleeding is often greater than expected due to qualitative platelet dysfunction. Myeloid malignancies are the most common, including acute myelogenous leukemia (and myelodysplastic syndrome. T- and B-cell acute lymphoblastic leukemias and lymphomas have also been reported, as well as skin manifestations (e.g., eczema, psoriasis).</Attribute>
                <XRef ID="NBK568319" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15329" />
                <XRef ID="15329" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">33661592</ID>
                <ID Source="BookShelf">NBK568319</ID>
              </Citation>
              <XRef ID="71290" DB="Orphanet" />
              <XRef ID="C1832388" DB="MedGen" />
              <XRef ID="C563324" DB="MeSH" />
              <XRef ID="MONDO:0100083" DB="MONDO" />
              <XRef Type="MIM" ID="601399" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="7814811" SubmissionDate="2023-12-11" DateLastUpdated="2023-12-17" DateCreated="2023-12-17">
        <ClinVarSubmissionID localKey="705119d9-ded3-44b9-97e6-4f50c9a0dc75" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004176258" DateUpdated="2023-12-17" DateCreated="2023-12-17" Type="SCV" Version="1" SubmitterName="ClinGen Myeloid Malignancy Variant Curation Expert Panel" OrgID="507107" OrganizationCategory="consortium" OrgAbbreviation="MyeloMalig_VCEP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-09">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/705119d9-ded3-44b9-97e6-4f50c9a0dc75</URL>
          </Citation>
          <Comment>The NM_001754.5(RUNX1):c.782dup (p.Gln262SerfsTer338) is a frameshift variant not expected to undergo nonsense-mediated mRNA decay. Nevertheless, the altered region is crucial for protein function, as it involves a duplication that impacts the established positions for frameshift (+1) variants (i.e., c.780-c.1440) (PVS1_Strong) and is positioned downstream of c.98 (in transcript NM_001754.4) (PM5_Supporting). This variant is entirely absent from all population databases (gnomAD v2.1.1, v3.1.2, and gnomAD v4.0.0) with at least 20x coverage for RUNX1 (PM2_supporting). To the best of our knowledge, this variant has not been reported in any study. In summary, this variant meets the criteria for a likely pathogenic classification, applying ACMG/AMP criteria specified by the Myeloid Malignancy Variant Curation Expert Panel for RUNX1: PVS1_Strong, PM2_Supporting, PM5_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen MyeloMalig ACMG Specifications v2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/g9fkgwq9/clingen_myelomalig_acmg_specifications_v2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001754.5(RUNX1):c.782dup</Name>
            <Name>p.Gln262fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.9:g.34834435dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0011071" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14033059</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5897011" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16832551|MedGen:C1832388" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003203868" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18723428</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22318203</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25840971</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31064749</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32208489</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the RUNX1 protein in which other variant(s) (p.Arg320*) have been determined to be pathogenic (PMID: 18723428, 22318203, 25840971, 31064749, 32208489; external communications). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This variant has not been reported in the literature in individuals affected with RUNX1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the RUNX1 gene (p.Gln262Serfs*338). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 219 amino acid(s) of the RUNX1 protein and extend the protein by 118 additional amino acid residues.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RUNX1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000021.8:g.36206729_36206730insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1832388" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5897011" TraitType="Disease" MappingType="XRef" MappingValue="C1832388" MappingRef="MedGen">
        <MedGen CUI="C1832388" Name="Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7814811" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0011071" MappingRef="MONDO">
        <MedGen CUI="CN281654" Name="Hereditary thrombocytopenia and hematologic cancer predisposition syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

